News

MY01 first in human test

When you really stand behind your product you don’t need to look too far for a volunteer to test it on. None other than our CEO Charles Allan was the volunteer for our first in-human test.

Mar 12th 2020
Feb 25th 2020
Another successful animal test

Another day, another success! Our animal testing has yet again demonstrated the abilities of our product.

MD&M West 2020 conference

George and Faisal at the Medical Design & Manufacturing (MD&M) West 2020 conference getting to visit our existing suppliers. They also took the opportunity to find new suppliers and technology for the manufacturing of MY01.

Feb 17th 2020
Feb 6th 2020
Abdel and Chris at Tech Fair 

 MY01 was born from a research project at McGill and we keep recruiting talent from our Alma Mater. For the second year in a row we had the opportunity to present our company to the engineering department and vet a good amount of new interns.

MUHC performs another cadaver test

Just a couple months after our initial trial at MUHC-RI, our team conducted another successful cadaver test.

Jan 28th 2020
Jan 9th 2020
MUHC performs a successful animal test 

As our recent rat test goes without a hitch , the team prepares as the first in-human test approaches.

MY01 and MUHC contribute to science

Our team has submitted 3 abstracts to EFORT in collaboration with MUHC. An effort that reaped high rewards as they all ended up being accepted for poster presentations. Due to the COVID situation, the conference was cancelled. Regardless, the abstracts are going to be featured in next year’s program.

Nov 21st 2019
Nov 20th 2019

SImon presents MY01 to the CHUM

Our CFO, Simon Sanscartier, giving a presentation on MY01 at the  InnovAction conference at the CHUM, a three day event focused around healthcare and value-based innovation in the Quebec biotechnology sphere.

First successful cadaver study

Our CMO, Dr. Ed Harvey, overseeing our first successful cadaver study at MUHC-RI with the help of Animesh. The first of many to come!

Nov 14th 2019
Sep 25th 2019
OTA 2019

Everybody we had contact with was positive. We were prominently mentioned in the compartment syndrome symposium as people referred to us as the only viable product for compartment syndrome.

MHSRS 2019

Ed and I presented a poster at the largest American Military conference of the year in Orlando, FL. Prolonged Field Care (PFC) was recognized as a key area of emphasis at the MHSRS. The MHSRS is an annual four-day educational symposium that draws approximately 2,900 attendees. We had the opportunity to discuss the advances of the MY01 device and the science behind it.

Aug 21st 2019
Aug 15th 2019
Visit to California

With the help of @MEDTEQ_CA our team (Anthony Sirgi and Faisal Al-Kabariti) went down to California to visit some of our suppliers, including ProTech. Visited current and potential new suppliers. Evaluated their capabilities to meet product specs. Explained Regulatory plan and expectations

MY01 meets the Minister of Economy and Innovation, Mr. Pierre Fitzgibbon 

Thanks to our partnership with C2Mi we had the opportunity to introduce Mr. Fitzgibbon to the MY01 device, we talked about our growth as a company in the biotechnology ecosystem in Montreal and in Quebec. Mr. Fitzgibbon was eager to know more about the technology and to see how the company grows.

Jun 27th 2019
Jun 10th 2019

Nxtsens was awarded a prize for exemplary integration of its immigrant workforce.

Most of our employees are first generation immigrants. They are all newly graduated in science or engineering from McGill University.  Some time ago, some of them expressed their interest in joining the Ordre des Ingénieurs du Québec. French being a requirement to join the OIQ, french classes have been implemented in the office.

Link to the video can be found here

McGill Clinical Innovation Competition Final

This year MY01 made it to the final of the McGil . Clinical Innovation Competition (CLIC). The CLIC competition was started in 2017 at McGill in order to recognize McGill Faculty members, including learners and graduates, who conceive and develop novel innovations that aim to improve healthcare and outcomes. Cooper delivered a Ted talk-style presentation in front a panel of judges is comprised of leaders in clinical care, academia, industry, engineering and business.

 

 

May 23rd 2019
May 17th 2019
GETRAUM 2019

MY01 is presented at the GETRAUM (Groupe d’Etude en TRAUMatologie; the Trauma Research Group) conference in Strasbourg, France. Among the most prominent orthopedic surgeons were presented and eager to try the MY01 device. We got the chance to discuss with a number of members of the European Federation of National Associations of Orthopedics and Traumatology (EFORT), the largest consortium of orthopedic and traumatology in Europe.

MY01 is presented at Medtech Strategist in Dublin

Simon flew to Dublin and got the chance to present at the Medtech Strategist event in Dublin. The event is recognized to be one of the leading medical technology investment forums in Europe. The presentation piqued the interest of doctors, Investors and distributors who are referring to our device as “the next big thing” in the ortho/trauma fields.

Apr 10th 2019
Mar 28th 2019

MY01 took the MTEC annual symposium by storm

Simon and Cooper flew down to Charleston, S.C. for the fourth Medical Technology Enterprise Consortium (MTEC)  symposium. The most prominent figures in American military medicine were present. MY01 delivered presentations both during a formal military pitch event and poster session. This opportunity positions MY01 to leverage further U.S. military funding opportunities.

MY01 gets a feature in La Voix de l’Est

Nxtsens and MY01 get a feature in the Quebec journal “La Voix de l’Est”. The journal focuses mostly on the regional development of Quebec and took a great interest in our technology, as well as in our involvement with C2Mi, a Bromont-based manufacturing facility. The full article can be found here.

Mar 20th 2019
Feb 24th 2019

Nxtsens presents MY01 in front of the Premier of Quebec

MY01 was presented to Quebec’s Prime Minister, Francois Legault, who announced a $26M grant to our partner C2Mi. In collaboration with C2MI, our joint team developed the most critical part of MY01 – its biocompatible microsensor and we are slated to receive $500k of that grant to subsidize the development of MY01 and its early production at C2Mi

Link to the article can be found here

MY01 presented at the SOMOS EWI Conference in Washington DC.

The government shutdown might have affected politicians and the FDA, but it didn’t slow the excitement of surgeons for MY01. Ed and I went down to Washington to present our device and the data the team gathered at the Society of Military Orthopaedic Surgeons Extremity War Injuries Conference (SOMOS EWI). While only having presenting a poster we drew the attention of many surgeons and further confirmed their excitement for the availability of MY01 as a tool for ACS diagnosis. We were able to communicate with physician decision makers for future market development and the ongoing funding of ACS research

Jan 22nd 2019
Jan 9th 2019

Intuitive process allowed surgeons to use MY01 within minutes – Sacre Coeur Hospital in Montreal

Anticipating the Montreal study kick-off Abdel, Cooper, and Dr. Harvey traveled uptown to meet the trauma team at Sacré-Coeur. We introduced the study goals, walked the surgeons, residents and researchers though the application and onboarding process, and had the opportunity to demonstrated the device functionality on a simulated fracture wound. The feedback and interest we received was overwhelmingly positive. Dr. Harvey commented on the noticeable physician excitement.

 ODT Journal Feature

MY01 was recently featured inOrthopedic Design and Technology Magazine. Dr. Harvey delivered some remarks on our competitive edge, and why early diagnosis of ACS is critical in driving better patient outcomes, and lowering the total cost of care. The full article can be found here

Nov 30th 2018
Sep 26th 2018

MY01 Wins at the Medtech Conference in Philadelphia

Simon and Charles traveled to Philadelphia to introduce MY01 to potential strategic companies and investors. Winning the best video award was a great PR opportunity at the event! M. Paul L’Archevesque, director of innovation at Ministry of Health and Social Services, was happy we won an award.

MY01 at the Orthopedic Trauma Association (OTA) Annual Meeting

Even without a booth, we made a splash at the 2018 OTA Annual Meeting. Ed presented MY01 in front of the Canadian Orthopedic Trauma Society (COTS) while devices were passed around. The final details of the Canadian study were reviewed by Dr. Ross Leighton (president of COTS) and there was a unanimous interest in participating. We also had the opportunity to meet with Dr. Schmidt, a world expert in compartment syndrome research, who will be including our device in the next two Major Extremity Trauma Research Consortium (METRC) study proposals. We met with surgeons from around the world who showed interest in our device and are excited to use it in their hospitals.

Oct 19th 2018
Oct 12th 2018
MY01 Presented at the International Society of Orthopaedic Surgery and Traumatology Conference (SICOT)

Dr. Harvey participated in several panels speaking on Acute Compartment Syndrome at SICOT. The consensus was clear that a better diagnostic tool for ACS was necessary to improve patient outcomes. From there, Dr. Harvey presented the most recent data from MY01 after which Dr. Schatzker (globally regarded in Trauma Care) mentioned the importance of this work! Meanwhile, our CFO, Simon was busy making European connections at SICOT’s closing dinner in Montreal.